Patent Assignment
Reel/Frame 029961/0298
Assignment of Assignor's Interest
Recorded: 2013-03-11
Pages: 2
Assignors
RIEDL, ROSEMARIE
Executed: 2013-02-27
THIRRING, KLAUS
Executed: 2013-02-25
HEILMAYER, WERNER
Executed: 2013-02-22
Assignee
NABRIVA THERAPEUTICS AG
LEBERSTRASSE 20, WIEN, 1110, AUSTRIA
Covered Property
(1)
Pleuromutilin Derivatives for Use in the Treatment of Diseases Mediated by Microbes
Related Assignments
(6)
Other recorded transfers of the patent in this record — the chain of ownership.
Lien
Sep 4, 2014
From: NABRIVA THERAPEUTICS AG
To: KREOS CAPITAL IV (UK) LIMITED
Reel/Frame 033686/0732 →
Cancellation of Lien
Nov 23, 2015
From: KREOS CAPITAL IV (UK) LIMITED
To: NABRIVA THERAPEUTICS AG
Reel/Frame 037152/0770 →
Intellectual Property Security Agreement
Dec 20, 2018
From: NABRIVA THERAPEUTICS GMBH
To: HERCULES CAPITAL, INC.
Reel/Frame 047973/0110 →
Release of Security Interest
Mar 3, 2023
From: HERCULES CAPITAL, INC.
To: NABRIVA THERAPEUTICS GMBH; ZAVANTE THERAPEUTICS, INC.
Reel/Frame 062881/0090 →
Corrective Assignment to Correct the Receiving Party Data and the Assignment Document Previously Recorded at Reel: 062881 Frame: 0090. Assignor(S) Hereby Confirms the Release of Security Interest.
Jun 20, 2023
From: HERCULES CAPITAL, INC.
To: NABRIVA THERAPEUTICS GMBH
Reel/Frame 064312/0350 →
Nunc Pro Tunc Assignment
Apr 3, 2025
From: NABRIVA THERAPEUTICS GMBH
To: HONG KONG KING-FRIEND INDUSTRIAL COMPANY LTD.
Reel/Frame 070725/0291 →